ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2017 American Transplant Congress

    Scoring of Distinct Tubular Injury Features and Assessment of Cellular Proliferation and of Non-Apoptotic Cell Death by the Novel Marker FACL4 Allow to Determine the Long-Term Prognosis of Renal Grafts.

    A. Bohlmann,1 J. Schmitz,1 A. Melk,1 R. Schmitt,1 I. Scheffner,1 V. Broeker,2 H. Haller,1 J. Metzger,3 J. Braesen,1 W. Gwinner.1

    1Hannover Medical School, Hannover, Germany; 2University of Gothenburg, Gothenburg, Sweden; 3Mosaiques Diagnostics, Hannover, Germany

    Acute tubular injury (ATI) is common in renal grafts and is related to an inferior long-term function. There is no consensus which of the tubular…
  • 2017 American Transplant Congress

    Endovascular Management of Transplant Renal Artery Stenosis: A Safe and Effective Treatment.

    A. Cavalcanti,1 M. Durao,1,2 B. Santos,1,2 E. Tonato,1,2 M. Doher,2 N. Guimaraes-Souza,1,2 L. Moreira Valle,1 B. Affonso,1 F. Nasser,1 A. Pacheco-Silva.1,2

    1Nephrology, Hospital Israelita Albert Einstein, São Paulo, Brazil; 2Nephrology, Universidade Federal de São Paulo, São Paulo, Brazil

    Background:Transplant Renal Artery Stenosis (TRAS) is a low incidence complication, but if untreated, can lead to graft failure, refractory hypertension (HT) and reduced life expectancy.…
  • 2017 American Transplant Congress

    Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.

    S. Hussain, T. Taber, M. Yaqub, O. Adebiyi, D. Mishler, A. Sharfuddin.

    Indiana University Health, Indianapolis

    Background: Chronic Hepatitis C Virus (HCV) infection has a negative impact on graft survival. Prior treatments were poorly tolerated and had minimal cure rates. The…
  • 2017 American Transplant Congress

    A Comparative Study of Patient and Graft Qualities Between Abo-Compatible and -Incompatible Recipients More Than Ten Years After Kidney Transplantation.

    H. Ishida, T. Shimizu, M. Okumi, K. Unagami, K. Omoto, K. Tanabe.

    Urology, Tokyo Women's Medical University, Tokyo, Japan

    Background. The long-term benefits of ABO-I kidney transplantation in terms of adverse events due to severe immunosuppression immediately before transplantation remain unclear.Patients and Methods. Between…
  • 2017 American Transplant Congress

    NFAT-Regulated Cytokine Gene Expression for Immune Monitoring in Kidney Transplant Recipients – A Randomized Controlled Trial.

    A. Webber,1 V. Tatapudi,2 C. Leung,3 F. Vincenti.1,3

    1Division of Nephrology, UCSF, San Francisco, CA; 2Division of Nephrology, NYUMC, New York, NY; 3Surgery, UCSF, San Francisco, CA

    Purpose: To demonstrate that a pharmacodynamics assay using Real Time (RT)-PCR to measure residual expression (RE) of nuclear factor of activated T cell (NFAT)-dependent cytokines…
  • 2017 American Transplant Congress

    Sequential Liver-Kidney Transplantation Is Equivalent to Simultaneous Liver–Kidney Transplantation in Candidates Requiring Dialysis Pre-Transplant.

    M. Mulvihill, B. Yerokun, R. Davis, K. Anderson, M. Hartwig, A. Barbas.

    Surgery, Duke University Medical Center, Durham, NC

    Introduction: Liver transplant is the optimal therapy for patients with end-stage liver disease (ESLD). Appropriately-selected candidates with renal impairment benefit from transplantation of liver and…
  • 2017 American Transplant Congress

    Waitlist Outcomes of Patients Re-Listed Following Failed Donation After Cardiac Death (DCD) Liver Transplant.

    K. Croome, D. Lee, A. Keaveny, C. Taner.

    Transplant, Mayo Clinic Florida, Jacksonville, FL

    Introduction: The outcome for patients re-listed after developing ischemic cholangiopathy(IC) or graft failure following liver transplant(LT) from a DCD donor, remains a significant concern. Better…
  • 2017 American Transplant Congress

    National Trends in Utilization of Donation After Cardiac Death Donor Livers for Transplantation.

    S. Kubal,1 R. Mangus,1 B. Ekser,1 R. Amos,2 J. Fridell.1

    1Department of Surgery, Division of Transplantation, Indiana University School of Medicine, Indianapolis, IN; 2Indiana Donor Network, Indianapolis, IN

    Background: Optimizing utilization of donation after cardiac death (DCD) livers is imperative to address organ shortage. Understanding factors that contribute to DCD liver discards is…
  • 2017 American Transplant Congress

    Survival Benefit of Liver Transplantation for Patients with MELD Spike.

    X. Luo, A. Massie, D. Segev.

    Johns Hopkins, Baltimore, MD

    We recently showed that patients with a recent sudden MELD increase of >30% over 7 days (MELD spike) have higher waitlist mortality than patients with…
  • 2017 American Transplant Congress

    Proposal for HCC Exception Points to Match Drop Out Risk.

    H. Yeh,3 M. Akan,1 N.-H. Leung,2 J. Markmann,3 S. Tayur.1

    1CMU, Pittsburgh; 2City U, Hong Kong, Hong Kong; 3MGH, Boston

    Background: Recent changes in HCC exception point policy aims to equalize wait list outcomes between HCC and non-HCC patients, but remains dissociated from tumor biology.…
  • « Previous Page
  • 1
  • …
  • 1110
  • 1111
  • 1112
  • 1113
  • 1114
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences